|
|
Article: Purdue Pharma L.P. Announces End of OxyContin(R) Patent Lawsuit With IMPAX Laboratories.
- Article from:
- PR Newswire
- Article date:
- May 25, 2007
CopyrightCOPYRIGHT 2007 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
STAMFORD, Conn., May 25 /PRNewswire/ -- Purdue Pharma L.P. announced today that the United States District Court for the Southern District of New York has granted a request by both companies to dismiss a lawsuit brought by Purdue against IMPAX concerning certain Purdue Pharma patents on OxyContin(R) (oxycodone HCl controlled-release) Tablets.
Under the terms of the settlement agreement announced on March 30th, 2007, IMPAX Laboratories has acknowledged that Purdue Pharma's OxyContin patents are valid, enforceable and infringed by IMPAX's extended-release oxycodone products and Purdue agreed it will not pursue damages against IMPAX for past infringement. Purdue ...